HIV-1 genotypic resistance in treatment-naive subjects enrolled in an observational trial (GAIN)

被引：0
|
作者：
Becker, MI
Haubrich, R
Wesselman, CW
Garrett, L
Lee, SY
Millard, D
Baxter, JD
机构：
[1] Agouron Pharmaceut Inc, La Jolla, CA USA
[2] UCSD, San Diego, CA USA
[3] Ingenix Pharmaceut Serv, Basking Ridge, NJ USA
[4] Consolidated Lab Serv, Van Nuys, CA USA
[5] RWJ Med Sch, Camden, NJ USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
161
引用
下载
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy
    Johnson, Jeffrey A.
    Li, Jin-Fen
    Wei, Xierong
    Lipscomb, Jonathan
    Irlbeck, David
    Craig, Charles
    Smith, Amanda
    Bennett, Diane E.
    Monsour, Michael
    Sandstrom, Paul
    Lanier, E. Randall
    Heneine, Walid
    PLOS MEDICINE, 2008, 5 (07) : 1112 - 1122
  • [32] Determinants of HIV-1 drug resistance in treatment-naive patients and its clinical implications in an antiretroviral treatment program in Cameroon
    Zoufaly, Alexander
    Jochum, Johannes
    Hammerl, Raffaela
    Nassimi, Nilofar
    Raymond, Yurika
    Burchard, Gerd-Dieter
    Schmiedel, Stefan
    Drexler, Jan-Felix
    Kay, Campbell Naomi
    Taka, Nchang
    Awasom, Charles
    Metzner, Karin
    Jan, van Lunzen
    Feldt, Torsten
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 83 - 84
  • [33] Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients
    Bon, Isabella
    Gibellini, Davide
    Borderi, Marco
    Alessandrini, Federica
    Vitone, Francesca
    Schiavone, Pasqua
    Re, Maria Carla
    JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (04) : 313 - 320
  • [34] Genetic Diversity of HIV-1 Gene vif Among Treatment-Naive Brazilians
    Villanoval, Fabiola
    Barreiros, Marta
    Janini, Luiz Mario
    Diaz, Ricardo Sobhie
    Leal, Elcio
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (09) : 952 - 959
  • [35] Urine creatinine in treatment-naive HIV subjects in eastern Nigeria
    Anyabolu, Ernest Ndukaife
    PAN AFRICAN MEDICAL JOURNAL, 2016, 25
  • [36] COST-EFFECTIVENESS OF DOLUTEGRAVIR IN HIV-1 TREATMENT-NAIVE PATIENTS IN RUSSIA
    Piercy, J.
    Jakubanis, R.
    Chounta, V
    Bukin, E.
    Kovalchuk, N.
    Punekar, Y. S.
    Holbrook, T.
    VALUE IN HEALTH, 2017, 20 (09) : A788 - A788
  • [37] Exploratory clinical studies of a synthetic HIV-1 Tat epitope vaccine in asymptomatic treatment-naive and antiretroviral-controlled HIV-1 infected subjects plus healthy uninfected subjects
    Goldstein, Gideon
    Chicca, John J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) : 479 - 485
  • [38] Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment-Naive Individuals Starting Modern Therapy Combinations
    von Wyl, Viktor
    Yerly, Sabine
    Boeni, Juerg
    Shah, Cyril
    Cellerai, Cristina
    Klimkait, Thomas
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Furrer, Hansjakob
    Hirschel, Bernard
    Vernazza, Pietro L.
    Ledergerber, Bruno
    Guenthard, Huldrych F.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (01) : 131 - 140
  • [39] Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016
    Huangbo Yuan
    Zhenqiu Liu
    Xuefu Wu
    Mingshan Wu
    Qiwen Fang
    Xin Zhang
    Tingting Shi
    Damien C. Tully
    Tiejun Zhang
    Archives of Virology, 2021, 166 : 2451 - 2460
  • [40] HIV-1 Diversity and Drug Resistance in Treatment-Naive Children and Adolescents from Rio de Janeiro, Brazil
    de Azevedo, Suwellen Sardinha Dias
    Delatorre, Edson
    Gaido, Cibele Marina
    Silva-de-Jesus, Carlos
    Guimaraes, Monick Lindenmeyer
    Couto-Fernandez, Jose Carlos
    Morgado, Mariza G.
    VIRUSES-BASEL, 2022, 14 (08):
12345